New hypothesis paper builds on a growing scientific consensus that Parkinson's disease route to the brain starts in either the nose or the gut and proposes that environmental toxicants are the likely source.
Parkinson's Disease: New theory on the disease's origins and spread." ScienceDaily. ScienceDaily, 11 April 2024. <www.sciencedaily.com
In Parkinson's disease, growing evidence targets neuroinflammation as essential for brain pathogenesis. But which group of immune cells that reside in the brain direct this inflammatory ... New research proposes that Alzheimer's disease may be driven by the overactivation of fructose made in the brain. The study outlined the hypothesis that Alzheimer's is a modern disease ...
Scientists suggest that the initial impact of environmental toxins inhaled through the nose may induce inflammation in the brain, triggering the production of Lewy bodies that can then be spread to ... Does Parkinson's disease start in the brain or the gut? In a new contribution, scientists hypothesize that PD can be divided into two subtypes: gut-first, originating in the peripheral ...Study Uses Artificial Intelligence to Show How Personality Influences the Expression of Our Genes
Chronic Illness Brain Tumor Diseases And Conditions Parkinson's Disorders And Syndromes Caregiving Brain-Computer Interfaces
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The Troubling Link Between Pesticides & Parkinson's Disease RiskOne more piece of the puzzle.
Read more »
Scientists Discover Dietary Supplement That Strongly Suppresses Parkinson’s Disease NeurodegenerationScience, Space and Technology News 2024
Read more »
Revolutionary Study Reveals High-Intensity Exercise May Reverse Parkinson’s Disease NeurodegenerationScience, Space and Technology News 2024
Read more »
Simulations reveal mechanism behind protein build-up in Parkinson's diseaseResearchers have used computational models to understand what drives the accumulation of alpha-synuclein protein, a key culprit in the development of Parkinson's disease.
Read more »
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trialThe drug, made by Sanofi, is a GLP-1 like Novo Nordisk’s blockbuster diabetes injection Ozempic and weight loss counterpart Wegovy
Read more »
Michael J. Fox on Decades-Long Battle With Parkinson's DiseaseMichael J. Fox reflected on living with Parkinson's disease more than 30 years after his diagnosis
Read more »